381 related articles for article (PubMed ID: 29953672)
1. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
[TBL] [Abstract][Full Text] [Related]
2. USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.
Yu J; Yuan S; Song J; Yu S
J Transl Med; 2023 Nov; 21(1):807. PubMed ID: 37957720
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.
Xing S; Tian Z; Zheng W; Yang W; Du N; Gu Y; Yin J; Liu H; Jia X; Huang D; Liu W; Deng M
Mol Cancer; 2021 Jan; 20(1):9. PubMed ID: 33407516
[TBL] [Abstract][Full Text] [Related]
4. Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.
Guo L; Ding Z; Huang N; Huang Z; Zhang N; Xia Z
Cell Cycle; 2017 Sep; 16(18):1705-1718. PubMed ID: 28767320
[TBL] [Abstract][Full Text] [Related]
5. [Forkhead Box M1 Regulates the Proliferation,Invasion,and Drug Resistance of Gastric Cancer Cells
Ge N; Jiang YY; Pan ZP; Wan J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):713-720. PubMed ID: 37927011
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy.
Lin JZ; Wang WW; Hu TT; Zhu GY; Li LN; Zhang CY; Xu Z; Yu HB; Wu HF; Zhu JG
Cancer Lett; 2020 Jan; 469():481-489. PubMed ID: 31738958
[TBL] [Abstract][Full Text] [Related]
7. Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer.
Liu SX; Zhou Y; Zhao L; Zhou LS; Sun J; Liu GJ; Du YS; Zhou YN
Free Radic Biol Med; 2022 Nov; 193(Pt 1):385-404. PubMed ID: 36152915
[TBL] [Abstract][Full Text] [Related]
8. 7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1.
Xiang HL; Liu F; Quan MF; Cao JG; Lv Y
World J Gastroenterol; 2012 Sep; 18(33):4618-26. PubMed ID: 22969238
[TBL] [Abstract][Full Text] [Related]
9. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.
Xin L; Zhou Q; Yuan YW; Zhou LQ; Liu L; Li SH; Liu C
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2507-2517. PubMed ID: 31485766
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the zinc-α2-glycoprotein accelerates apoptosis and inhibits growth via the mTOR/PTEN signaling pathway in gastric carcinoma cells.
Li W; Liu J
Life Sci; 2020 Jan; 240():117117. PubMed ID: 31790689
[TBL] [Abstract][Full Text] [Related]
12. SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1.
Wu J; Qin W; Wang Y; Sadik A; Liu J; Wang Y; Song P; Wang X; Sun K; Zeng J; Wang L
J Cell Biochem; 2018 Nov; 119(11):9042-9054. PubMed ID: 30076647
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines.
Zhang B; Liu LL; Mao X; Zhang DH
Mol Med Rep; 2014 Dec; 10(6):3193-8. PubMed ID: 25310131
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
16. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
17. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1.
Yu J; Wang X; Li Y; Tang B
Oncol Rep; 2017 Mar; 37(3):1394-1400. PubMed ID: 28184921
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.
Feng J; Wang X; Zhu W; Chen S; Feng C
Biochemistry (Mosc); 2017 Jun; 82(6):707-714. PubMed ID: 28601080
[TBL] [Abstract][Full Text] [Related]
20. Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer.
Li L; Fan B; Zhang LH; Xing XF; Cheng XJ; Wang XH; Guo T; Du H; Wen XZ; Ji JF
Tumour Biol; 2016 Aug; 37(8):10269-78. PubMed ID: 26831669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]